Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianantonio Saviola

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Rheumatology International|May 18, 2010
Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real lifeMaurizio Benucci, Gianantonio Saviola, Paola Baiardi, et al.
Current Rheumatology Reviews|September 29, 2022
Mesenchymal Cells are a Promising -But Still Unsatisfying- Anti- Inflammatory Therapeutic Strategy for Osteoarthritis: A Narrative ReviewSergio Rosini, Gianantonio Saviola, Laura Comini, et al.
Recenti Progressi in Medicina|March 16, 2006
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]Maurizio Benucci, Stefano Dolenti, Gianantonio Saviola, et al.
Current Rheumatology Reviews|January 8, 2025
Clodronate: The Influence on ATP Purinergic SignalingSergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Minerva Medica|August 5, 2024
Adenosine triphosphate: a new player in complex regional pain syndrome type 1Sergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Rheumatology International|July 29, 2010
Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two casesGianantonio Saviola, Lul Abdi-Ali, Paola Baiardi, et al.
Rheumatology International|May 22, 2008
Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab)Maurizio Benucci, Francesca Li Gobbi, Gianantonio Saviola, et al.
Clinical Rheumatology|October 12, 2007
Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritisMaurizio Benucci, Gianantonio Saviola, Paola Baiardi, et al.
Current Rheumatology Reviews|October 7, 2021
Role of the Osteochondral Unit in the Pathogenesis of Osteoarthritis: Focus on the Potential Use of ClodronateLuigi Molfetta, Andrea Casabella, Sergio Rosini, et al.
Biologics : Targets & Therapy|March 26, 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritisMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Rheumatology International|May 18, 2010
Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real lifeMaurizio Benucci, Gianantonio Saviola, Paola Baiardi, et al.
Current Rheumatology Reviews|September 29, 2022
Mesenchymal Cells are a Promising -But Still Unsatisfying- Anti- Inflammatory Therapeutic Strategy for Osteoarthritis: A Narrative ReviewSergio Rosini, Gianantonio Saviola, Laura Comini, et al.
Recenti Progressi in Medicina|March 16, 2006
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]Maurizio Benucci, Stefano Dolenti, Gianantonio Saviola, et al.
Current Rheumatology Reviews|January 8, 2025
Clodronate: The Influence on ATP Purinergic SignalingSergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Minerva Medica|August 5, 2024
Adenosine triphosphate: a new player in complex regional pain syndrome type 1Sergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Rheumatology International|July 29, 2010
Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two casesGianantonio Saviola, Lul Abdi-Ali, Paola Baiardi, et al.
Rheumatology International|May 22, 2008
Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab)Maurizio Benucci, Francesca Li Gobbi, Gianantonio Saviola, et al.
Clinical Rheumatology|October 12, 2007
Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritisMaurizio Benucci, Gianantonio Saviola, Paola Baiardi, et al.
Current Rheumatology Reviews|October 7, 2021
Role of the Osteochondral Unit in the Pathogenesis of Osteoarthritis: Focus on the Potential Use of ClodronateLuigi Molfetta, Andrea Casabella, Sergio Rosini, et al.
Biologics : Targets & Therapy|March 26, 2013
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritisMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Pageof 3